Tirzepatide did not impact metabolic adaptation in people with obesity, but increased fat oxidation.

Saved in:
Bibliographic Details
Title: Tirzepatide did not impact metabolic adaptation in people with obesity, but increased fat oxidation.
Authors: Ravussin E; Pennington Biomedical Research Center, Baton Rouge, LA, USA., Sanchez-Delgado G; Pennington Biomedical Research Center, Baton Rouge, LA, USA; Department of Medicine, Division of Endocrinology, Center de Recherche du Center Hospitalier de Sherbrooke, Université de Sherbrooke, Sherbrooke, QC, Canada; Sport and Health University Research Institute and Institute of Nutrition and Food Technology 'José Mataix', University of Granada, Granada, Spain; Instituto de Investigación Biosanitaria Ibs. Granada, Granada, Spain; CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain., Martin CK; Pennington Biomedical Research Center, Baton Rouge, LA, USA., Beyl RA; Pennington Biomedical Research Center, Baton Rouge, LA, USA., Greenway FL; Pennington Biomedical Research Center, Baton Rouge, LA, USA., O'Farrell LS; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Roell WC; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Qian HR; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Li J; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Nishiyama H; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Haupt A; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Pratt EJ; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Urva S; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Milicevic Z; Eli Lilly and Company, Vienna, Austria., Coskun T; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA. Electronic address: coskun_tamer@lilly.com.
Source: Cell metabolism [Cell Metab] 2025 May 06; Vol. 37 (5), pp. 1060-1074.e4. Date of Electronic Publication: 2025 Apr 08.
Publication Type: Journal Article; Clinical Trial, Phase I; Randomized Controlled Trial
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101233170 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1932-7420 (Electronic) Linking ISSN: 15504131 NLM ISO Abbreviation: Cell Metab Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1932-7420
DOI:10.1016/j.cmet.2025.03.011